RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tonix Pharmaceuticals Holding Stock

Tonix Pharmaceuticals Holding Equity 2025

Tonix Pharmaceuticals Holding Equity

139.56 M USD

Ticker

TNXP

ISIN

US8902608392

WKN

A2PUSY

In 2025, Tonix Pharmaceuticals Holding's equity was 139.56 M USD, a 32.25% increase from the 105.53 M USD equity in the previous year.

Tonix Pharmaceuticals Holding Aktienanalyse

What does Tonix Pharmaceuticals Holding do?

Tonix Pharmaceuticals Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Tonix Pharmaceuticals Holding's Equity

Tonix Pharmaceuticals Holding's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Tonix Pharmaceuticals Holding's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Tonix Pharmaceuticals Holding's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Tonix Pharmaceuticals Holding's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Tonix Pharmaceuticals Holding’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Tonix Pharmaceuticals Holding stock

What is the equity of Tonix Pharmaceuticals Holding this year?

Tonix Pharmaceuticals Holding has equity of 139.56 M USD this year.

What was the equity of Tonix Pharmaceuticals Holding compared to the previous year?

The equity of Tonix Pharmaceuticals Holding has increased/decreased by 32.25% increased compared to the previous year.

What impact does a high equity have on investors of Tonix Pharmaceuticals Holding?

A high equity is advantageous for investors of Tonix Pharmaceuticals Holding as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Tonix Pharmaceuticals Holding?

A low equity can be a risk for investors of Tonix Pharmaceuticals Holding, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Tonix Pharmaceuticals Holding affect the company?

An increase in equity of Tonix Pharmaceuticals Holding can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Tonix Pharmaceuticals Holding affect the company?

A reduction in equity of Tonix Pharmaceuticals Holding can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Tonix Pharmaceuticals Holding?

Some factors that can affect the equity of Tonix Pharmaceuticals Holding include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Tonix Pharmaceuticals Holding so important for investors?

The equity of Tonix Pharmaceuticals Holding is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Tonix Pharmaceuticals Holding take to change the equity?

To change equity, Tonix Pharmaceuticals Holding can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Tonix Pharmaceuticals Holding pay?

Over the past 12 months, Tonix Pharmaceuticals Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tonix Pharmaceuticals Holding is expected to pay a dividend of 0 USD.

What is the dividend yield of Tonix Pharmaceuticals Holding?

The current dividend yield of Tonix Pharmaceuticals Holding is .

When does Tonix Pharmaceuticals Holding pay dividends?

Tonix Pharmaceuticals Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tonix Pharmaceuticals Holding?

Tonix Pharmaceuticals Holding paid dividends every year for the past 0 years.

What is the dividend of Tonix Pharmaceuticals Holding?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tonix Pharmaceuticals Holding located?

Tonix Pharmaceuticals Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tonix Pharmaceuticals Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tonix Pharmaceuticals Holding from 8/10/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/10/2025.

When did Tonix Pharmaceuticals Holding pay the last dividend?

The last dividend was paid out on 8/10/2025.

What was the dividend of Tonix Pharmaceuticals Holding in the year 2024?

In the year 2024, Tonix Pharmaceuticals Holding distributed 0 USD as dividends.

In which currency does Tonix Pharmaceuticals Holding pay out the dividend?

The dividends of Tonix Pharmaceuticals Holding are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tonix Pharmaceuticals Holding

Our stock analysis for Tonix Pharmaceuticals Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tonix Pharmaceuticals Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.